Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptors, Androgen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07711002
What this trial is testing

Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
AstraZeneca 1,330
Early research (Phase 1)Looking for participantsNCT06631521
What this trial is testing

Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate CAProstate Cancer (Adenocarcinoma)Prostate Cancer Surgery
AdventHealth 30
Very early researchLooking for participantsNCT03068910
What this trial is testing

Hyperandrogenemia and Altered Day-night LH Pulse Patterns

Who this might be right for
HyperandrogenismPolycystic Ovary SyndromePuberty
University of Virginia 32
Early research (Phase 1)Ended earlyNCT00972023
What this trial is testing

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03090165
What this trial is testing

Ribociclib and Bicalutamide in AR+ TNBC

Who this might be right for
Triple Negative Breast Cancer
Kari Wisinski 37
Not applicableLooking for participantsNCT07181122
What this trial is testing

Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Ankara Etlik City Hospital 102
Post-approval studies (Phase 4)Active Not RecruitingNCT03016741
What this trial is testing

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Who this might be right for
Castration-Resistant Prostatic CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+2 more
Northwestern University 100
Testing effectiveness (Phase 2)Ended earlyNCT02379390
What this trial is testing

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Who this might be right for
Prostate Cancer Metastatic
Sanofi 8
Testing effectiveness (Phase 2)Looking for participantsNCT06348264
What this trial is testing

Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma

Who this might be right for
Salivary Gland Neoplasm Duct
Peking University First Hospital 37
Testing effectiveness (Phase 2)Ended earlyNCT04754425
What this trial is testing

Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaCastration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted AgentsMetastatic Malignant Neoplasm in the Bone+5 more
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT03297385
What this trial is testing

Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation

Who this might be right for
Prostate CancerDNAAndrogen Receptor Abnormal
The Netherlands Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT01289574
What this trial is testing

Topical ASC-J9 Cream for Acne

Who this might be right for
Acne
AndroScience Corp 181
Early research (Phase 1)Ended earlyNCT04279561
What this trial is testing

Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8+2 more
Jonsson Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT04381832
What this trial is testing

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-ResistantAndrogen-Resistant Prostatic NeoplasmsCastration Resistant Prostatic Neoplasms+1 more
Arcus Biosciences, Inc. 173
Not applicableNot Yet RecruitingNCT06838520
What this trial is testing

Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
The First Affiliated Hospital with Nanjing Medical University 200
Early research (Phase 1)Active Not RecruitingNCT04662580
What this trial is testing

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Janssen Research & Development, LLC 183
Testing effectiveness (Phase 2)Study completedNCT00878436
What this trial is testing

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 52
Early research (Phase 1)Ended earlyNCT03150056
What this trial is testing

Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer

Who this might be right for
Solid Tumours
GlaxoSmithKline 73
Testing effectiveness (Phase 2)Study completedNCT02499497
What this trial is testing

A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 114
Very early researchStudy completedNCT03507608
What this trial is testing

Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Next Page